Prognostic Value of BRAF, Programmed Cell Death 1 (PD1), and PD Ligand 1 (PDL1) Protein Expression in Colon Adenocarcinoma

Patients with colorectal cancer in different stages show variable outcomes/therapeutic responses due to their distinct tumoral biomarkers and biological features. In this sense, this study aimed to explore the prognostic utility of BRAF, programmed death-1 (PD1), and its ligand (PDL1) protein signat...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Afaf T. Ibrahiem, Entsar Eladl, Eman A. Toraih, Manal S. Fawzy, Khaled Abdelwahab, Khaled Elnaghi, Ziad Emarah, Aly A. M. Shaalan, Ziad Ehab, Nahed A. Soliman
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2023-01-01
Saila:	Diagnostics
Gaiak:	BRAF colorectal cancer protein expression PD1 PDL1 prognosis
Sarrera elektronikoa:	https://www.mdpi.com/2075-4418/13/2/237
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!